Use of HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells as a Potential Therapeutic for Progressive HER2-Positive Glioblastoma

Schneider Julia R.; Kwan Kevin; Boockvar John A.

首页> 外文期刊>Neurosurgery >Use of HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells as a Potential Therapeutic for Progressive HER2-Positive Glioblastoma

【24h】

Use of HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells as a Potential Therapeutic for Progressive HER2-Positive Glioblastoma

机译：使用HER2特异性嵌合抗原受体改性病毒特异性T细胞作为进步HER2阳性胶质母细胞瘤的潜在治疗方法

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Neurosurgery》 |2017年第5期|共3页
作者
Schneider Julia R.; Kwan Kevin; Boockvar John A.;
展开▼
作者单位

Lenox Hill Hosp Dept Neurosurg Brain Tumor Ctr New York NY 10021 USA;

Lenox Hill Hosp Dept Neurosurg Brain Tumor Ctr New York NY 10021 USA;

Lenox Hill Hosp Dept Neurosurg Brain Tumor Ctr New York NY 10021 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类头部及神经外科学;
关键词

相似文献

外文文献
中文文献
专利

1. 嵌合T细胞受体N29γ的T细胞靶向性治疗p185 HER2阳性鼠乳腺癌肺转移 [J] . 李升平, Frank A. Urban, Jennifer N. MacGregor, 癌症（英文版） . 2004,第0z1期
2. Use of HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells as a Potential Therapeutic for Progressive HER2-Positive Glioblastoma [J] . Schneider Julia R., Kwan Kevin, Boockvar John A. Clinical neurosurgery. . 2017,第5期

机译：HER2特异性嵌合抗原受体修饰的病毒特异性T细胞作为进行性HER2阳性胶质母细胞瘤的潜在疗法的用途
3. Use of HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells as a Potential Therapeutic for Progressive HER2-Positive Glioblastoma [J] . Schneider Julia R., Kwan Kevin, Boockvar John A. Neurosurgery . 2017,第5期

机译：使用HER2特异性嵌合抗原受体改性病毒特异性T细胞作为进步HER2阳性胶质母细胞瘤的潜在治疗方法
4. Use of HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells as a Potential Therapeutic for Progressive HER2-Positive Glioblastoma [J] . Schneider Julia R., Kwan Kevin, Boockvar John A. Neurosurgery . 2017,第5期

机译：使用HER2特异性嵌合抗原受体改性病毒特异性T细胞作为进步HER2阳性胶质母细胞瘤的潜在治疗方法
5. ENHANCEMENT OF VIRUS-SPECIFIC IMMUNE RESPONSES USING AQUEOUS-BASED MICROCAPSULES TARGETED TO SPECIFIC ANTIGEN PRESENTING CELLS [C] . C. Moser, D. Dolfi, K. Macartney, International symposium on controlled release of bioactive materials;Consumer diversified products conference . 2001

机译：使用针对特定抗原呈递细胞的水基微胶囊增强病毒特异性免疫反应
6. The Curative Potential of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Malignancies. [D] . Koduri, Megha Pallavi. 2017

机译：嵌合抗原受体T细胞疗法对B细胞恶性肿瘤的治疗潜力。
7. HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma [O] . Nabil Ahmed, Vita Brawley, Meenakshi Hegde, -1

机译：进行性胶质母细胞瘤的HER2特异性嵌合抗原受体修饰的病毒特异性T细胞
8. Use of HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells as a Potential Therapeutic for Progressive HER2-Positive Glioblastoma [O] . Julia R. Schneider, Kevin Kwan, John A. Boockvar 2017

机译：使用HER2特异性嵌合抗原受体改性病毒特异性T细胞作为进步HER2阳性胶质母细胞瘤的潜在治疗方法
9. Analysis of Tumor Antigen-Specific Tc1 and Tc2 CD8 Effector Cell Subpopulations as Potential Therapeutics Agents in the Treatment of Progressive Breast [R] . Dobrzanski, M. J. 2004

机译：肿瘤抗原特异性Tc1和Tc2 CD8效应细胞亚群作为治疗进展性乳腺癌的潜在治疗药物的分析

Use of HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells as a Potential Therapeutic for Progressive HER2-Positive Glioblastoma

著录项

相似文献

相关主题

期刊订阅